Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

  • Bacharier L
  • Maspero J
  • Katelaris C
  • et al.
171Citations
Citations of this article
163Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Children with moderate-to-severe asthma continue to have disease complications despite the receipt of standard-of-care therapy. The monoclonal antibody dupilumab has been approv...

Cite

CITATION STYLE

APA

Bacharier, L. B., Maspero, J. F., Katelaris, C. H., Fiocchi, A. G., Gagnon, R., de Mir, I., … Hardin, M. (2021). Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma. New England Journal of Medicine, 385(24), 2230–2240. https://doi.org/10.1056/nejmoa2106567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free